Table:
begin	end	state
1	20	cytoplasmic
21	51	transmembrane
52	56	non-cytoplasmic
57	81	transmembrane
82	93	cytoplasmic
94	117	transmembrane
118	126	non-cytoplasmic
127	148	transmembrane
149	160	cytoplasmic
161	180	transmembrane
181	191	non-cytoplasmic
192	211	transmembrane
212	241	cytoplasmic
242	262	transmembrane
263	273	non-cytoplasmic
274	295	transmembrane
296	306	cytoplasmic
307	326	transmembrane
327	331	non-cytoplasmic
332	356	transmembrane
357	369	cytoplasmic
370	393	transmembrane
394	401	non-cytoplasmic
402	420	transmembrane
421	427	cytoplasmic

Input:
>BPHYT_RS08740 FitnessBrowser__BFirm:BPHYT_RS08740
MSTSTLQASAARPSAAKVHRIILAASIGNALEWFDLVVYGFFAVTIAKLFFPARTEAISL
MLTLGTFGISYMIRPLGGLVLGSLADRAGRKASLLLSIALMMVGTLTIAVMPPYAAIGLW
APAGIMLSRLVQGFSAGGEFGASTAFLVEHAPERRGFMGSWQFASQGMATLLASGFGALL
TSQLTSAQLESWGWRVPFLFGLAIGPVGFYIRRYVDEGAEFNAEPKARTPLRDLFGTQKV
RMLLAVGSLIISTAANYMILYMPTYAIKQLHLPASTGFAATLATGVVLTVLTPFAGHLSD
RLGRIRIMATAAVLMLVTVYPAFVYMNAHPSFVTMLLALIWIGVLKATYFGALPALMSEI
FPTQTRATGLAVSYNIGVTVFGGFAPFVITWLIDASGNKLAPGFYLMFCAVASLLALYAV
RGRLKIR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server